C1827106||DIPEPTIDYL PEPTIDASE-4 INHIBITORS
C0242656||PROGRESSION
C0011884||DIABETIC RETINOPATHY
C0011860||TYPE 2 DIABETES
C1827106||dipeptidyl peptidase-4 inhibitors
C1827106||dipeptidyl peptidase-4 inhibitors
C0242656||progression
C0011884||diabetic retinopathy
C0011884||diabetic retinopathy
C0011860||Type 2 diabetes
C0011884||diabetic retinopathy
C0025102||medical records
C0011860||Type 2 diabetes
C0200189||Fundus photographs
C0441800||graded
C3899277||Early Treatment Diabetic Retinopathy Study methods
C0035648||risk factors
C0242656||progression
C0011884||diabetic retinopathy
C1827106||DPP4 inhibitors
C0020616||hypoglycemic agents
C0242656||progression
C0011884||retinopathy
C1827106||DPP4 inhibitors
C0242656||progression
C0011884||diabetic retinopathy
C1827106||DPP4 inhibitors
C0011884||diabetic retinopathy
C0242656||progression
C1827106||DPP4 inhibitors
C0242656||progression
C0011884||diabetic retinopathy
C0243095||improving glycemic control
C1827106||DPP4 inhibitors
C0011884||diabetic retinopathy
C0242656||progression
C0220825||evaluation
C1827106||DPP4 inhibitors
C0242656||progression
C0011884||diabetic retinopathy
C0034656||randomized
C0013072||double-blind